LLY

1,045.02

-0.7%↓

JNJ

203.41

+0.38%↑

ABBV

229.54

-0.76%↓

UNH

311.8

+1.55%↑

AZN

88.66

-0.2%↓

LLY

1,045.02

-0.7%↓

JNJ

203.41

+0.38%↑

ABBV

229.54

-0.76%↓

UNH

311.8

+1.55%↑

AZN

88.66

-0.2%↓

LLY

1,045.02

-0.7%↓

JNJ

203.41

+0.38%↑

ABBV

229.54

-0.76%↓

UNH

311.8

+1.55%↑

AZN

88.66

-0.2%↓

LLY

1,045.02

-0.7%↓

JNJ

203.41

+0.38%↑

ABBV

229.54

-0.76%↓

UNH

311.8

+1.55%↑

AZN

88.66

-0.2%↓

LLY

1,045.02

-0.7%↓

JNJ

203.41

+0.38%↑

ABBV

229.54

-0.76%↓

UNH

311.8

+1.55%↑

AZN

88.66

-0.2%↓

Home・Akciju saraksts・NeoGenomics Inc

NeoGenomics Inc

Atvērts

10.68 3.99

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

10.26

Max

11.05

Galvenie mērījumi
By Trading Economics
Ienākumi	18M -27M
Pārdošana	6.5M 188M
EPS	0.03
Peļņas marža	-14.446
Darbinieki	2,200
EBITDA	38M -10M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+27.67% upside

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	9.9M 1.3B
Iepriekšējā atvēršanas cena	6.69
Iepriekšējā slēgšanas cena	10.68

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

7.7 / 10.27 Atbalsts un pretestība

NeoGenomics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 18. nov. 16:25 UTC

Galvenie tirgus virzītāji

Diginex Rises on Deal With Digital Asset Platform Evident

2025. g. 14. nov. 17:45 UTC

Peļņas

Galvenie tirgus virzītāji

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

2025. g. 14. nov. 17:31 UTC

Peļņas

Galvenie tirgus virzītāji

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

2025. g. 13. nov. 19:28 UTC

Galvenie tirgus virzītāji

Robinhood Shares Slide After Cash Delivery Service Rollout

2025. g. 19. nov. 12:39 UTC

Tirgus saruna

Regulation Could Curb Demand For Stablecoins -- Market Talk

2025. g. 19. nov. 12:39 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 19. nov. 08:02 UTC

Tirgus saruna

Bitcoin Stays Under Pressure Ahead of Key Releases -- Market Talk

2025. g. 18. nov. 12:23 UTC

Peļņas

Contradictions Abound for Investors as Nvidia Earnings Loom Large -- Barrons.com

2025. g. 18. nov. 12:04 UTC

Iegādes, apvienošanās, pārņemšana

Cypherpunk Purchases Additional $18M of ZEC, Bringing Total Network Percentage to 1.43%

2025. g. 18. nov. 12:00 UTC

Tirgus saruna

Bitcoin Could Fall Further on Uncertainty Over Fed Rate Cuts -- Market Talk

2025. g. 18. nov. 08:07 UTC

Tirgus saruna

Bitcoin Falls as Risk Aversion Intensifies -- Market Talk

2025. g. 17. nov. 15:40 UTC

Iegādes, apvienošanās, pārņemšana

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

2025. g. 17. nov. 11:53 UTC

Tirgus saruna

ECB's Warning on Stablecoins Looks Overblown -- Market Talk

2025. g. 17. nov. 08:03 UTC

Tirgus saruna

Bitcoin Struggles to Recover as Risk Appetite Stays Weak -- Market Talk

2025. g. 14. nov. 10:43 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 14. nov. 10:43 UTC

Tirgus saruna

Bitcoin Loses Support From Previously Reliable Investment Sources -- Market Talk

2025. g. 14. nov. 07:41 UTC

Tirgus saruna

Bitcoin Hits 6-Month Low Following U.S. Tech-Stock Selloff -- Market Talk

2025. g. 13. nov. 21:23 UTC

Peļņas

Intchains Group 3Q Rev $1.3M >ICG

2025. g. 13. nov. 12:08 UTC

Iegādes, apvienošanās, pārņemšana

Intchains Group to Acquire a Proof-of-Stake Technology Platform, and Expand Blockchain Infrastructure Capabilities

2025. g. 13. nov. 09:29 UTC

Tirgus saruna

Stablecoin Growth Expected by Treasury Secretary Could Have Big Implications -- Market Talk

2025. g. 13. nov. 08:23 UTC

Tirgus saruna

Bitcoin Edges Higher as U.S. Government Shutdown Ends -- Market Talk

2025. g. 12. nov. 08:09 UTC

Tirgus saruna

Bitcoin Edges Higher on U.S. Government Reopening Hopes -- Market Talk

2025. g. 12. nov. 08:09 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 11. nov. 08:53 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 11. nov. 08:53 UTC

Tirgus saruna

Bitcoin Eases on Renewed U.S.-China Trade Concerns -- Market Talk

2025. g. 10. nov. 08:05 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 10. nov. 08:05 UTC

Tirgus saruna

Bitcoin Rises on Hopes For End to U.S. Government Shutdown -- Market Talk

2025. g. 7. nov. 13:02 UTC

Tirgus saruna

Bitcoin Falls Back Below $100,000 on Risk Aversion -- Market Talk

2025. g. 7. nov. 08:12 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 7. nov. 08:12 UTC

Tirgus saruna

Bitcoin Struggles For Meaningful Recovery in Wake of Selloff -- Market Talk

Salīdzinājums

Cenas izmaiņa

NeoGenomics Inc Prognoze

Cenas mērķis

By TipRanks

27.67% augšup

Prognoze 12 mēnešiem

Vidējais 13.29 USD 27.67%

Augstākais 17 USD

Zemākais 11 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

11 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 11 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

7.7 / 10.27Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bearish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.